3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Glioblastoma
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Renal Insufficiency
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Melanoma
1
Lung Neoplasms
1
Liver Failure
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioma
1
Interventions
Cyclophosphamide
29
fludarabine phosphate
22
Whole-Body Irradiation
20
Mycophenolic Acid
20
fludarabine
19
asciminib
19
nilotinib
16
Tacrolimus
13
Imatinib Mesylate
13
Melphalan
11
Dasatinib
9
Sirolimus
8
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
bosutinib
6
Mesna
6
Cyclosporine
6
ponatinib
5
Stem Cell Transplantation
5
Filgrastim
5
venetoclax
4
ruxolitinib
4
blinatumomab
4
Specimen Handling
4
Cyclosporins
4
thymoglobulin
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
veliparib
×
1 year
×
Clear all
No trials found.